Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The ESCRS EPICAT Study
NCT05158699Phase 3Terminated
- Start
- Oct 2021
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of triamcinolone, ketorolac tromethamine in cystoid macular edema (CME). Started Oct 2021; status: terminated.
02
Drugs
triamcinoloneketorolac tromethamine
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT05158699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05158699.